| Literature DB >> 29629395 |
Dong-Hyun Kim1,2, Andrew C Larson1,2,3,4,5.
Abstract
The efficacy of conventional transarterial chemoembolization (TACE) approaches in liver cancer treatment is limited by the lack of effective drug carriers and/or the inability to monitor drug delivery to the targeted tumor tissues. Recent years have seen rapid advances in drug carriers for TACE. Bioabsorbable and MRI- or CT-visible microspheres that are trackable in vivo have been developed as a form of nanocomposite. Herein, we review notable progress in nanocomposite microspheres drug carriers available for TACE.Entities:
Keywords: hepatocellular carcinoma; microspheres; nanocomposite; transarterial chemoembolization
Year: 2016 PMID: 29629395 PMCID: PMC5889143
Source DB: PubMed Journal: Interv Oncol 360 ISSN: 2332-5151